Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC

BSE8878.7552.05 (+0.59 %)

PREV CLOSE ( ) 8826.70

OPEN PRICE ( ) 8751.05

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 725

TODAY'S LOW / HIGH ( )8650.00 8990.00

52 WK LOW / HIGH ( )6501.6 10653.05

NSE8919.0095 (+1.08 %)

PREV CLOSE( ) 8824.00

OPEN PRICE ( ) 8829.50

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 8919.00 (36)

VOLUME 9284

TODAY'S LOW / HIGH( ) 8641.00 9000.00

52 WK LOW / HIGH ( )6620.1 10691

Chairman	Shilpa Divekar Nirula
Executive Director	Praveen Rao Akkinepally
Non Executive Director	Jesus Javier Diaz Ropero Esteso Sylvia Lorena Varela Ramon Hooi-Bien Chuah
Non Executive Independent Director	Revathy Ashok Monica Widhani
Whole Time Director	Bhavana Agrawal

Incorporation Year : 11-07 1979

Registered Office :

Address : Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring Road Bengaluru,
Karnataka-560045 .

Phone : 080 6774 8000

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE